Low-dose prednisone accounts for a transient reduction on CD4+ and CD8+ T cells in renal transplant patients under triple therapy.
Sauma
D
D
Unidad de Trasplante, Clínica Las Condes, Santiago, Chile.
Mora
J R
JR
Fierro
A
A
Morales
J
J
Herzog
C
C
Buckel
E
E
Rosemblatt
M
M
Bono
M R
MR
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000493:pharmacokinetics / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D018655:Lymphocyte Count; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011241:Prednisone / Q000493:pharmacokinetics / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone